🍷 DYK? New research suggests that even minimal alcohol consumption can lead to an increased risk of 10 different types of cancer, including breast, pancreatic, liver, and prostate cancer. Learn more in @people: bit.ly/4vp3kqp #CancerRisk #CancerResearch

What do patients wish they had known when they first heard the words, “you have cancer”? In this powerful conversation, three cancer survivors share what it was really like to navigate diagnosis, treatment decisions, and immunotherapy - often without the guidance or support they needed. Their experiences helped shape Hope in Action: A Patient’s Guide to Cancer Immunotherapy, created to help patients and families feel more informed, supported, and empowered from the very beginning. If cancer has impacted you or someone you love, this discussion offers honest insight, reassurance, and hope from people who have lived it. @CancerResearch Watch here: oncodaily.com/voices/immunot…

How can mRNA vaccines transform cancer treatment? Explore the results of a promising new study, in @Forbes: bit.ly/43cS3h6 #CancerResearch #Immunotherapy #Melanoma

According to research presented at the American Society of Clinical Oncology’s annual meeting, new clinical trial results demonstrated that a personalized mRNA vaccine halved the risk of melanoma returning after five years. Explore with @NBCNews: nbcnews.to/4dT2USc #melnm

A melanoma diagnosis can feel overwhelming - but no one should have to face it alone. The Cancer Research Institute (@CancerResearch)’s Melanoma Patient Guide was created to help patients and families better understand immunotherapy, treatment options, potential side effects, and important questions to ask throughout care. Because feeling informed can help patients move forward with greater confidence, clarity, and support. Explore the guide: oncodaily.com/voices/melanom…

Survival stories like Jenney’s are why immunotherapy research matters. Every breakthrough in the lab has the potential to become someone’s second chance at life. Read more of her story: bit.ly/49HGFxp #Melanoma #MelanomaResearch

Think of the dark proteome like a room full of mystery keys. Most keys in the body are well labelled and we know what they do. But these dark ones? No labels. No instructions. Meet the ILLUMINE team on the hunt to discover whether (and how) these dark proteins influence some of the toughest cancers. Learn more about ILLUMINE 👉 youtube.com/watch?v=vYYhnrTd… --- ILLUMINE is funded by @CR_UK, @theNCI, @CancerResearch and KiKa (Children Cancer Free Foundation) through Cancer Grand Challenges.

Scientific progress is rarely linear. At #AACR26, Drs. Ken Murphy and Crystal Mackall explored how decades of foundational immunology research laid the groundwork for today’s cancer immunotherapies, and where the field may go next. Learn more in our blog: bit.ly/4u1mmSL

A colorectal cancer diagnosis can change everything in an instant. For patients and families, clear and trusted information can make the path forward feel more manageable. The Cancer Research Institute’s (@CancerResearch) Colorectal Cancer Patient Guide helps explain immunotherapy, treatment planning, possible side effects, and support resources — empowering patients to navigate treatment decisions with greater confidence. Explore the guide: oncodaily.com/voices/immunot…

Gordon had exhausted nearly every treatment option to fight stage 4 colorectal cancer. Discover how a second opinion and a new immunotherapy combination changed everything: bit.ly/432YKlQ #CancerResearch #Immunotherapy

What’s the difference between colon cancer and rectal cancer? Does immunotherapy work for everyone with colorectal cancer? Get answers to your most requently asked questions, in A Patient’s Guide to Cancer Immunotherapy: Colorectal Cancer: bit.ly/4wVZZAP #CRC

How much do healthy lifestyle habits, such as diet and exercise, matter after a cancer diagnosis? @SylvesterCancer's Dr. Sekeres shares his expert opinion with @washingtonpost: wapo.st/4o3zOnZ #CancerRisk #CancerResearch

👩‍🔬 The CRI Bioinformatics Bootcamp invests in training the next generation of researchers in emerging technologies and computational approaches that are transforming cancer research. Meet the alumni helping drive the future of immunotherapy research: bit.ly/4anmt3Y

The future of biology starts with better data. Thank you to @GrinsteinJ of @Inside_PM for moderating a great discussion between @ay_zhou of @CancerResearch and our CEO Serge Saxonov on AI, biological data and the future of discovery. Watch on demand: bit.ly/4vui47F

A holy grail for our lab has been tracking myeloid cells in human tumors in the same way that we track T and B cells with TCR/BCR. @vincentzliu and @CalebLareau solved it! We developed Mitotrek using scATAC-seq mitochondrial DNA to do exactly this. Using Mitotrek, we find that new myeloid cells clones constantly infiltrate the tumor via circulating monocytes — and that their macrophage or dendritic cell fate is epigenetically programmed before tumor entry. @10xGenomics @parkerici @CancerResearch @TheMarkFdn cell.com/cancer-cell/fulltex…

🎧On the latest episode of TED Health, CRI's CEO Dr. Zhou discusses how immunotherapy is transforming cancer care, why investing in scientists is as important as investing in science, and how AI and data could help accelerate the next gen of breakthroughs: apple.co/43K5gOs

Cancer immunotherapy is entering a new era of momentum. From emerging modalities and clinical breakthroughs to the expanding real-world impact for patients, the field continues to reshape what’s possible in cancer care. The 2026 CRI Cancer Immunotherapy Insights Impact Report offers a comprehensive look at the science, innovation, and progress driving the future of immuno-oncology. We’re proud to partner with the Cancer Research Institute (@CancerResearch) to help amplify these advances and the global effort behind them. Read the report: cancerresearch.org/cancer-im… #CancerImmunotherapy #CancerResearchInstitute

Join CRI's CEO Dr. Alicia Zhou and @10xGenomics' CEO and co-founder Dr. Serge Saxonov as they discuss how the CRI Discovery Engine is helping power the next era of precision immunotherapy, at @Inside_PM's 2026 State of Precision Medicine virtual summit: bit.ly/49SxbPM

Oswald's response to immunotherapy transformed a stage 4 lung cancer diagnosis into a second chance at life. To the researchers, clinicians, and scientists who are advancing immunotherapy every day: this is the impact of your work. More: bit.ly/4uTaX93 #CancerResearch

This Wednesday, our CEO Serge Saxonov joins @ay_zhou of @CancerResearch at the @Inside_PM Virtual Summit to discuss how AI and high-resolution biology are converging to enable predictive models for cancer discovery. Register here: bit.ly/4dUio8D